6 results match your criteria: "Josai University 1-1 Keyakidai[Affiliation]"
RSC Med Chem
October 2024
Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University 5-9-1 Shirokane, Minato-ku Tokyo 108-8641 Japan
RSC Med Chem
September 2024
Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University 5-9-1 Shirokane Minato-ku Tokyo 108-8641 Japan
The incorporation of saturated nitrogen-containing heterocycle 1,2,5-oxadiazinane into small molecules represents a compelling avenue in drug discovery due to its unexplored behavior within biological systems and incomplete protocols for synthesis. In this study, we present 1,2,5-oxadiazinane, an innovative heterocyclic bioisostere of piperizin-2-one and novel chemotype of the -schistosomal drug praziquantel (PZQ), which has been the only clinical drug available for three decades. PZQ is associated with significant drawbacks, including poor solubility, a bitter taste, and low metabolic stability.
View Article and Find Full Text PDFRSC Adv
February 2022
Faculty of Pharmacy and Pharmaceutical Sciences, Josai University 1-1 Keyakidai, Sakado Saitama 350-0295 Japan +81-49-271-7052 +81-49-271-7052.
We report a novel smart micellar system utilising a phenylboronic acid (PBA) derivative whose viscosity increases on adding diol compounds such as sugar or sugar alcohol. We prepared a typical worm-like micelle (WLM) system in 100 mM cetyltrimethylammonium bromide (CTAB)/70 mM sodium salicylate (NaSal), which showed high zero-shear viscosity ( ). Upon the addition of 20 mM 3-fluorophenylboronic acid (3FPBA) to the WLM system, decreased by 1/300 that of the system without 3FPBA.
View Article and Find Full Text PDFAm J Transl Res
December 2019
Department of Applied Biochemistry, School of Pharmacy, Tokyo University of Pharmacy & Life Sciences 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
Background: To provide novel insight into the development of new therapeutic strategies to combat breast cancer, differentiation-inducing activity of clinically achievable concentrations of arsenite (As) and tetrandrine (Tetra) was investigated in breast cancer cell lines MDA-MB-231 and MCF-7.
Methods: Differentiation induction of cancer cells was analyzed by flow cytometer. Alterations of genes related to differentiation, and proliferation of human normal peripheral blood mononuclear cells (PBMCs) were analyzed using western blotting and cell viability assay, respectively.
Am J Cancer Res
August 2019
Laboratory of Pharmacology, School of Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.
Cancer is a diverse class of diseases characterized by uncontrolled cell growth with the potential to invade and spread to other parts of the body, and continues to be one of the leading causes of death worldwide. Conventional cancer treatment modalities include antitumor drugs, surgical resection, locally targeted therapies such as radiation therapy. Along with improved understanding of the molecular pathogenesis of various cancers, generation and the use of smart targeted anti-cancer drugs have been challenged.
View Article and Find Full Text PDFEur J Pharmacol
February 2009
Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Josai University. 1-1 Keyakidai, Sakado City, Saitama 350-0295, Japan.
We investigated the effects of tumor necrosis factor (TNF)-alpha on DNA synthesis and proliferation, and its signal transduction pathways in primary cultures of adult rat hepatocytes. TNF-alpha induced time- and dose-dependent increases in hepatocyte DNA synthesis and proliferation. The hepatocyte proliferation stimulated by 30 ng/ml TNF-alpha was significantly inhibited by anti-TNF receptor 2 antibody, but not by anti-TNF receptor 1 antibody.
View Article and Find Full Text PDF